STOCK TITAN

[8-K] Crescent Energy Company Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.

Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di 12,34 $ per soddisfare obblighi fiscali e di busta paga legati a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione serve esclusivamente per l'assolvimento fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e a 11.278 azioni indirette detenute tramite The Short Revocable Living Trust, lasciando invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati, né sono state comunicate altre attività da parte degli insider. Data la dimensione trascurabile (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentiment degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional de un insider, el Científico Jefe Robert D. Short III, el 07/07/2025. La compañía retuvo 50 acciones comunes (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionadas con premios de acciones restringidas previamente otorgados. La nota explicativa confirma que la transacción es estrictamente para liquidación fiscal y no implica una venta en el mercado abierto.

Después de la transacción, la propiedad directa es de 31,848 acciones y 11,278 acciones indirectas mantenidas a través del The Short Revocable Living Trust, manteniendo la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se revelaron otras actividades de insiders. Dado el tamaño insignificante (≈0.1 % de las tenencias totales de Short) y su naturaleza administrativa, la presentación tiene limitada relevancia para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 판매와는 무관함을 확인합니다.

거래 후 소유권은 31,848 직접 보유 주식과 The Short Revocable Living Trust를 통해 보유한 11,278 간접 보유 주식으로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권은 행사, 취득 또는 처분되지 않았으며, 다른 내부자 활동도 공개되지 않았습니다. 거래 규모가 미미(Short 전체 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이번 제출은 투자 의미가 제한적이며 VirnetX에 대한 내부자 심리 변화 신호가 아닙니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement à régler des impôts et n’implique pas une vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, ce qui laisse l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initiés n’a été divulguée. Étant donné la taille négligeable (≈0,1 % des avoirs totaux de Short) et la nature administrative, cette déclaration présente une signification limitée pour les investisseurs et ne signale aucun changement de sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion durch den Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von 12,34 $ ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über den The Short Revocable Living Trust, wodurch seine wirtschaftliche Gesamtposition im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insider-Aktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (ca. 0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Only 50 shares withheld for taxes; negligible impact and neutral signal.

The Code F designation reveals an automatic share surrender to cover tax obligations on vested stock, a routine event that does not reflect a discretionary buy or sell decision. Post-withholding, the insider still controls roughly 43 k shares, indicating sustained alignment with shareholders. Because the transaction involves less than 1 % of his position and no derivatives, liquidity or valuation impact is essentially nil. From a governance and sentiment perspective, the filing is neutral; it neither strengthens nor weakens the investment case for VHC.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di 12,34 $ per soddisfare obblighi fiscali e di busta paga legati a precedenti assegnazioni di azioni vincolate. La nota esplicativa conferma che la transazione serve esclusivamente per l'assolvimento fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e a 11.278 azioni indirette detenute tramite The Short Revocable Living Trust, lasciando invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati, né sono state comunicate altre attività da parte degli insider. Data la dimensione trascurabile (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentiment degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional de un insider, el Científico Jefe Robert D. Short III, el 07/07/2025. La compañía retuvo 50 acciones comunes (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones de nómina e impuestos relacionadas con premios de acciones restringidas previamente otorgados. La nota explicativa confirma que la transacción es estrictamente para liquidación fiscal y no implica una venta en el mercado abierto.

Después de la transacción, la propiedad directa es de 31,848 acciones y 11,278 acciones indirectas mantenidas a través del The Short Revocable Living Trust, manteniendo la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se revelaron otras actividades de insiders. Dado el tamaño insignificante (≈0.1 % de las tenencias totales de Short) y su naturaleza administrativa, la presentación tiene limitada relevancia para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 판매와는 무관함을 확인합니다.

거래 후 소유권은 31,848 직접 보유 주식과 The Short Revocable Living Trust를 통해 보유한 11,278 간접 보유 주식으로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권은 행사, 취득 또는 처분되지 않았으며, 다른 내부자 활동도 공개되지 않았습니다. 거래 규모가 미미(Short 전체 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이번 제출은 투자 의미가 제한적이며 VirnetX에 대한 내부자 심리 변화 신호가 아닙니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement à régler des impôts et n’implique pas une vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, ce qui laisse l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initiés n’a été divulguée. Étant donné la taille négligeable (≈0,1 % des avoirs totaux de Short) et la nature administrative, cette déclaration présente une signification limitée pour les investisseurs et ne signale aucun changement de sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion durch den Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von 12,34 $ ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über den The Short Revocable Living Trust, wodurch seine wirtschaftliche Gesamtposition im Wesentlichen unverändert bleibt. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insider-Aktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (ca. 0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung begrenzte investitionsrelevante Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

0001866175False00018661752025-07-082025-07-08


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 8, 2025
Crescent Energy Company
(Exact name of registrant as specified in its charter)
Delaware001-4113287-1133610
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
600 Travis Street, Suite 7200,
Houston, Texas    77002
(Address of principal executive offices) (Zip Code)
Registrant’s Telephone Number, including Area Code:
(713) 332-7001
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per shareCRGYNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 1.01.    Entry into a Material Definitive Agreement.
The information contained in Item 2.03 of this Current Report is incorporated into this Item 1.01 by reference.
Item 2.03.    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
On July 8, 2025, Crescent Energy Finance LLC, a Delaware limited liability company (the “Issuer”) and indirect subsidiary of Crescent Energy Company (NYSE: CRGY) (the “Company”), issued $600.0 million aggregate principal amount of its 8.375% Senior Notes due 2034 (the “Notes”). The Notes were issued pursuant to the indenture, dated as of July 8, 2025 (the “Indenture”), by and among the Issuer, the guarantors named therein (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Additional information regarding the Notes and the Indenture, pursuant to which such Notes were issued, is set forth below.
Indenture and Senior Notes
The Notes are senior unsecured obligations of the Issuer. The Notes are fully and unconditionally guaranteed on a senior unsecured basis by the existing subsidiaries of the Issuer that guarantee its indebtedness under its revolving credit facility. The Notes are not guaranteed by the Company, which is the managing member of Crescent Energy OpCo LLC (“OpCo”), which is the sole member of the Issuer, or OpCo, and neither the Company nor OpCo is subject to the terms of the Indenture.
Maturity and Interest
The Notes will mature on January 15, 2034. The Notes bear interest at the rate of 8.375% per annum, payable in arrears on each January 15 and July 15, with interest payments on the Notes commencing January 15, 2026.
Optional Redemption
At any time prior to July 15, 2028, the Issuer may redeem up to 40% of the aggregate principal amount of the Notes with an amount of cash not greater than the net cash proceeds of certain equity offerings at a redemption price equal to 108.375% of the principal amount of the Notes redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, if at least 50% of the aggregate principal amount of the Notes remains outstanding immediately after such redemption and the redemption occurs within 180 days of the closing date of such equity offering.
At any time prior to July 15, 2028, the Issuer may, on any one or more occasions, redeem all or a part of the Notes at a redemption price equal to 100% of the principal amount of the Notes redeemed, plus a “make-whole” premium and accrued and unpaid interest, if any, to, but excluding, the redemption date.
On or after July 15, 2028, the Issuer may redeem the Notes, in whole or in part, at the redemption prices set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date, if redeemed during the twelve-month period beginning on July 15 of the years indicated below:
YearPercentage
2028104.188%
2029102.094%
2030 and thereafter100.000%
Change of Control
If the Issuer experiences certain kinds of changes of control accompanied by a ratings decline, each holder of the Notes may require the Issuer to repurchase all or a portion of its Notes for cash at a price equal to 101% of the
2


aggregate principal amount of such Notes, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date.
Certain Covenants
The Indenture contains covenants that, among other things, limit the ability of the Issuer’s restricted subsidiaries to: (i) incur or guarantee additional indebtedness or issue certain types of preferred stock; (ii) pay dividends or distributions in respect of its equity or redeem, repurchase or retire its equity or subordinated indebtedness; (iii) transfer or sell assets; (iv) make investments; (v) create certain liens; (vi) enter into agreements that restrict dividends or other payments from any non-Guarantor restricted subsidiary to it; (vii) consolidate, merge or transfer all or substantially all of its assets; (viii) engage in transactions with affiliates; and (ix) create unrestricted subsidiaries.
Events of Default
If an Event of Default (as defined in the Indenture) occurs and is continuing under the Indenture, the Trustee or holders of at least 30% in principal amount of the then total outstanding Notes by written notice to the Issuer and the Trustee may declare the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Notes to be due and payable immediately; provided that the Notes will be due and payable immediately without further action or notice if such an Event of Default results from certain events of bankruptcy or insolvency with respect to the Issuer, any restricted subsidiary of the Issuer that is a significant subsidiary or any group of restricted subsidiaries of the Issuer that, taken together, would constitute a significant subsidiary.
The foregoing description of the Indenture is not complete and is qualified in its entirety by reference to the full text of the Indenture, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference.
Item 7.01.    Regulation FD Disclosure.
On July 8, 2025, the Issuer issued a news release announcing the early results and early settlement date for its cash tender offer (the “Tender Offer”) to purchase up to $500,000,000 of the outstanding aggregate principal amount of its 9.250% Senior Notes due 2028 (the “2028 Notes”) pursuant to that certain indenture, dated as of February 1, 2023, by and among the Issuer, the guarantors named therein and the Trustee. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
As of July 7, 2025, $306,125,000 aggregate principal amount of the 2028 Notes (approximately 30.61%) was validly tendered. The Issuer accepted for payment all such 2028 Notes validly tendered and not validly withdrawn in the Tender Offer and made payment for such 2028 Notes on July 9, 2025.
This Current Report on Form 8-K does not constitute an offer to purchase nor a solicitation of an offer to sell any 2028 Notes in the Tender Offer. The Tender Offer is only being made pursuant to the Offer to Purchase, dated June 23, 2025. The Tender Offer is not being made to holders of 2028 Notes in any state or jurisdiction in which the making or acceptance thereof would be unlawful under the securities laws of any such jurisdiction.
The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
3


Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits.
ExhibitDescription
4.1
Indenture, dated as of July 8, 2025, among Crescent Energy Finance LLC, the guarantors named therein, and U.S. Bank Trust Company, National Association, as trustee.
99.1
Press Release, dated July 8, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
4


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 11, 2025
CRESCENT ENERGY COMPANY
By:/s/ Bo Shi
Name:Bo Shi
Title:General Counsel

5

FAQ

What did VirnetX (VHC) disclose in the latest Form 4?

The company reported that Chief Scientist Robert D. Short III had 50 shares withheld on 07/07/2025 to cover tax obligations.

Was the 50-share transaction an open-market sale of VHC stock?

No. The shares were automatically withheld by VirnetX for taxes (Transaction Code F), not sold on the open market.

How many VirnetX shares does Robert D. Short III hold after the transaction?

He owns 31,848 shares directly and 11,278 shares indirectly via The Short Revocable Living Trust.

Did the filing report any derivative securities activity?

No derivative securities were acquired, exercised, or disposed of in this Form 4.

What is the investment significance of this Form 4 for VHC shareholders?

The filing is largely administrative; the small tax-withholding action does not indicate a change in insider sentiment or company outlook.
Crescent Energy Company

NYSE:CRGY

CRGY Rankings

CRGY Latest News

CRGY Latest SEC Filings

CRGY Stock Data

2.33B
244.03M
5.45%
97.47%
9.37%
Oil & Gas Integrated
Crude Petroleum & Natural Gas
Link
United States
HOUSTON